UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Challenges of driving CD30-directed CAR-T cells to the clinic

BMC cancer, 2019-03, Vol.19 (1), p.203-203, Article 203

2019

Volltextzugriff (PDF)

Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies

Blood, 2016-06, Vol.127 (26), p.3350-3359

2016

Volltextzugriff (PDF)

NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma

Clinical cancer research, 2019-12, Vol.25 (23), p.7126-7138

2019

Volltextzugriff (PDF)

Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors

PloS one, 2015-12, Vol.10 (12), p.e0144787-e0144787

2015

Volltextzugriff (PDF)

Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration

Nature communications, 2022-04, Vol.13 (1), p.2154-12, Article 2154

2022

Volltextzugriff (PDF)

Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

The New England journal of medicine, 2011-11, Vol.365 (18), p.1673-1683

2011

Volltextzugriff (PDF)

Building safety into CAR-T therapy

Human vaccines & immunotherapeutics, 2023-12, Vol.19 (3), p.2275457-2275457

2023

Volltextzugriff (PDF)

IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity

Nature communications, 2024-01, Vol.15 (1), p.89-16, Article 89

2024

Volltextzugriff (PDF)

Author Correction: IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity

Nature communications, 2024-06, Vol.15 (1), p.5182-1

2024

Volltextzugriff (PDF)

Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003897

2022

Volltextzugriff (PDF)

Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells

Journal for immunotherapy of cancer, 2021-09, Vol.9 (9), p.e002737

2021

Volltextzugriff (PDF)

Immune Checkpoint Modulation in Colorectal Cancer: What’s New and What to Expect

Journal of Immunology Research, 2015-01, Vol.2015 (2015), p.1-16

2015

Volltextzugriff (PDF)

Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling

Cancer immunology research, 2021-04, Vol.9 (4), p.441-453

2021

Volltextzugriff (PDF)

Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells

Clinical cancer research, 2009-09, Vol.15 (18), p.5852-5860

2009

Volltextzugriff (PDF)

Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β

Molecular therapy. Methods & clinical development, 2022-12, Vol.27, p.415-430

2022

Volltextzugriff (PDF)

Genetic modification of human T lymphocytes for the treatment of hematologic malignancies

Haematologica (Roma), 2012-11, Vol.97 (11), p.1622-1631

2012

Volltextzugriff (PDF)

Chimeric antigen receptor T-cell therapy targeting CD30 in Hodgkin lymphoma

Clinical advances in hematology & oncology, 2021-01, Vol.19 (1), p.24

Savoldo, Barbara

2021

Volltextzugriff (PDF)

Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy

Journal of Immunology Research, 2016-01, Vol.2016 (2016), p.1-7

2016

Volltextzugriff (PDF)

CAR T cells for hematological malignancies

The Journal of clinical investigation, 2024-01, Vol.134 (2), p.1-3

2024

Volltextzugriff (PDF)

Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas

Journal for immunotherapy of cancer, 2023-08, Vol.11 (8), p.e006959

2023

Volltextzugriff (PDF)

Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients

American journal of transplantation, 2005-09, Vol.5 (9), p.2222-2228

2005

Volltextzugriff (PDF)

Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease

Haematologica (Roma), 2013-04, Vol.98 (4), p.533-537

2013

Volltextzugriff (PDF)

Treating hematological malignancies with cell therapy: where are we now?

Expert opinion on biological therapy, 2018-01, Vol.18 (1), p.65-75

2018

Volltextzugriff (PDF)

Adoptive T cell therapy: Boosting the immune system to fight cancer

Seminars in immunology, 2020-06, Vol.49, p.101437-101437, Article 101437

2020

Volltextzugriff (PDF)

Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15

Clinical cancer research, 2019-05, Vol.25 (9), p.2915-2924

2019

Volltextzugriff (PDF)

1 – 25 von 265

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(247)
Mit Volltextzugriff
(236)

Publikationsform

Artikel
(261)
Buchkapitel
(3)
Texte
(1)

Sprache

Englisch
(265)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(145)
Life Sciences & Biomedicine
(142)
Humans
(128)
Oncology
(55)
Animals
(54)
Hematology
(50)
Immunotherapy
(45)
Biological And Medical Sciences
(42)
Medical Sciences
(41)
Mice
(39)
Male
(37)
Female
(36)
Lymphocytes
(35)
T-Lymphocytes - Immunology
(35)
Immunology
(32)
Antigens
(31)
Medicine, Research & Experimental
(29)
Research & Experimental Medicine
(29)
T-Lymphocytes, Cytotoxic - Immunology
(27)
Lymphocytes T
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Challenges of driving CD30-directed CAR-T cells to the clinic

Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies

NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma

Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors

Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration

Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

Building safety into CAR-T therapy

IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity

Author Correction: IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity

Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer

Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells

Immune Checkpoint Modulation in Colorectal Cancer: What’s New and What to Expect

Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic Signaling

Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells

Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β

Genetic modification of human T lymphocytes for the treatment of hematologic malignancies

Chimeric antigen receptor T-cell therapy targeting CD30 in Hodgkin lymphoma

Involvement of HMGB1 in Resistance to Tumor Vessel-Targeted, Monoclonal Antibody-Based Immunotherapy

CAR T cells for hematological malignancies

Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas

Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients

Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease

Treating hematological malignancies with cell therapy: where are we now?

Adoptive T cell therapy: Boosting the immune system to fight cancer

Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15

Suchergebnisse filtern